The global laser BPH devices market was valued at $460.3 million in 2021, and is projected to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Benign prostatic hyperplasia (BPH) is also called prostate gland enlargement which is a common condition as men get older. An enlarged prostate gland can cause uncomfortable urinary symptoms, such as blocking the flow of urine out of the bladder. It can also cause bladder, urinary tract, or kidney problems. The severity of symptoms in people who have prostate gland enlargement varies, but symptoms tend to gradually worsen over time. Common signs and symptoms of BPH include Frequent or urgent need to urinate, increased frequency of urination at night, difficulty starting urination, weak urine stream or a stream that stops and starts, dribbling at the end of urination, inability to completely empty the bladder.
During prostate laser surgery, the doctor inserts a scope delivers through the tip of the penis into the tube that carries urine from the bladder (urethra). The prostate surrounds the urethra. The laser is passed through the scope delivers energy that shrinks or removes excess tissue that is preventing urine flow.
The growth of laser BPH devices market is driven by technological advancement for development of different laser BPH devices and rise in the prevalence of benign prostatic hyperplasia. In addition, increase in number of various strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. For instance, according to report shared by The Lancet Article, in 2019, approximately 94 million population is suffering from benign prostatic hyperplasia over the globe.
Geriatric population is more susceptible to benign prostatic hyperplasia. Thus, increase in the number of geriatric populations is anticipated to drive the demand for laser BPH devices and boost the market growth. In addition, increase in prevalence of diabetes and rise in prevalence of obesity is anticipated to increase the risk of BPH. Thus, this factor is anticipated to drive the demand for laser BPH device for treatment purpose and drives the growth of market. For instance, according to report shared by International Diabetes Federation, in 2021, it was reported that, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
In addition, rise in the expenditure by government to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for laser BPH devices for treatment of benign prostatic hyperplasia, thereby boosting the market growth. On the other hand, high cost of treatment and side effects of the procedures are some factors that are anticipated to restrain the growth of the laser BPH devices market.
The laser BPH devices market is segmented based on type, procedure, end user and region. Based on type the market is segmented into holmium laser, thulium laser, green light laser, and others. On the basis of procedure, the market is segmented into photo selective vaporization of the Prostate (PVP) and holmium laser ablation of the prostate (HoLAP). On the basis of end user, the market is segmented into hospitals, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global laser BPH devices market include Boston Scientific, Agiliti Health, Inc., Asclepion Laser Technologies GmbH, Biolitec AG., Coloplast, Endo Pharmaceuticals Inc., HealthTronics, Inc., Lumenis, Metrum Cryoflex, OmniGuide and Richard Wolf GmbH.
During prostate laser surgery, the doctor inserts a scope delivers through the tip of the penis into the tube that carries urine from the bladder (urethra). The prostate surrounds the urethra. The laser is passed through the scope delivers energy that shrinks or removes excess tissue that is preventing urine flow.
The growth of laser BPH devices market is driven by technological advancement for development of different laser BPH devices and rise in the prevalence of benign prostatic hyperplasia. In addition, increase in number of various strategies such as product launch and product approval by the market key players is anticipated to drive the growth of market. For instance, according to report shared by The Lancet Article, in 2019, approximately 94 million population is suffering from benign prostatic hyperplasia over the globe.
Geriatric population is more susceptible to benign prostatic hyperplasia. Thus, increase in the number of geriatric populations is anticipated to drive the demand for laser BPH devices and boost the market growth. In addition, increase in prevalence of diabetes and rise in prevalence of obesity is anticipated to increase the risk of BPH. Thus, this factor is anticipated to drive the demand for laser BPH device for treatment purpose and drives the growth of market. For instance, according to report shared by International Diabetes Federation, in 2021, it was reported that, approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.
In addition, rise in the expenditure by government to develop healthcare infrastructure is anticipated to drive the market growth. For instance, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.0% of the gross domestic product (GDP) in 2020, as compared to 9.9% in 2019. Furthermore, it has been estimated that 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure, especially medical equipment used at public health centers, such as hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for laser BPH devices for treatment of benign prostatic hyperplasia, thereby boosting the market growth. On the other hand, high cost of treatment and side effects of the procedures are some factors that are anticipated to restrain the growth of the laser BPH devices market.
The laser BPH devices market is segmented based on type, procedure, end user and region. Based on type the market is segmented into holmium laser, thulium laser, green light laser, and others. On the basis of procedure, the market is segmented into photo selective vaporization of the Prostate (PVP) and holmium laser ablation of the prostate (HoLAP). On the basis of end user, the market is segmented into hospitals, clinics, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global laser BPH devices market include Boston Scientific, Agiliti Health, Inc., Asclepion Laser Technologies GmbH, Biolitec AG., Coloplast, Endo Pharmaceuticals Inc., HealthTronics, Inc., Lumenis, Metrum Cryoflex, OmniGuide and Richard Wolf GmbH.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the laser bph devices market analysis from 2021 to 2031 to identify the prevailing laser bph devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the laser bph devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global laser bph devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Holmium laser
- Thulium laser
- Green light laser
- Others
By Procedure
- Photoselective Vaporisation of the Prostate
- Holmium laser ablation of the prostate
By End User
- Hospitals
- Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Boston Scientific Corporation
- OmniGuide
- Metrum Cryoflex
- Richard Wolf GmbH
- Coloplast
- Biolitec AG
- Agiliti Health, Inc.
- HealthTronics, Inc.
- Endo Pharmaceuticals Inc.
- Teleflex Incorporated
Table of Contents
CHAPTER 1: INTRODUCTION1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. High bargaining power of suppliers
3.3.2. Moderate bargaining power of buyers
3.3.3. High threat of substitutes
3.3.4. High threat of new entrants
3.3.5. High intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in the prevalence of benign prostate hyperplasia
3.4.1.2. Rise in the number of geriatric populations
3.4.1.3. Rise in the prevalence of obesity
3.4.1.4. Increase in the prevalence of diabetes
3.4.2. Restraints
3.4.2.1. Side effects of laser BPH surgery
3.4.2.2. High cost of laser BPH surgery
3.4.3. Opportunities
3.4.3.1. Increase in the number of adoptions of key strategies by market players
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: LASER BPH DEVICES MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Holmium laser
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Thulium laser
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Green light laser
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Others
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: LASER BPH DEVICES MARKET, BY PROCEDURE
5.1. Overview
5.1.1. Market size and forecast
5.2. Photoselective Vaporisation of the Prostate
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Holmium laser ablation of the prostate
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: LASER BPH DEVICES MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: LASER BPH DEVICES MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Procedure
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Procedure
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Procedure
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Procedure
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Procedure
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Procedure
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Procedure
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Procedure
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Procedure
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Procedure
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Procedure
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Procedure
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Procedure
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Procedure
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Procedure
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Procedure
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Procedure
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Procedure
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Procedure
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Procedure
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Procedure
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Procedure
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Procedure
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Coloplast
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.3. Biolitec AG
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. Richard Wolf GmbH
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Agiliti Health, Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. HealthTronics, Inc.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Endo Pharmaceuticals Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. OmniGuide
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Metrum Cryoflex
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Teleflex Incorporated
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 02. Laser Bph Devices Market for Holmium Laser, by Region, 2021-2031 (Revenue, $Million)
Table 03. Laser Bph Devices Market for Thulium Laser, by Region, 2021-2031 (Revenue, $Million)
Table 04. Laser Bph Devices Market for Green Light Laser, by Region, 2021-2031 (Revenue, $Million)
Table 05. Laser Bph Devices Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 06. Global Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 07. Laser Bph Devices Market for Photoselective Vaporisation of the Prostate, by Region, 2021-2031 (Revenue, $Million)
Table 08. Laser Bph Devices Market for Holmium Laser Ablation of the Prostate, by Region, 2021-2031 (Revenue, $Million)
Table 09. Global Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 10. Laser Bph Devices Market for Hospitals, by Region, 2021-2031 (Revenue, $Million)
Table 11. Laser Bph Devices Market for Clinics, by Region, 2021-2031 (Revenue, $Million)
Table 12. Laser Bph Devices Market for Others, by Region, 2021-2031 (Revenue, $Million)
Table 13. Laser Bph Devices Market, by Region, 2021-2031 (Revenue, $Million)
Table 14. North America Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 15. North America Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 16. North America Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 17. North America Laser Bph Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 18. U.S. Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 19. U.S. Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 20. U.S. Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 21. Canada Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 22. Canada Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 23. Canada Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 24. Mexico Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 25. Mexico Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 26. Mexico Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 27. Europe Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 28. Europe Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 29. Europe Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 30. Europe Laser Bph Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 31. Germany Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 32. Germany Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 33. Germany Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 34. France Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 35. France Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 36. France Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 37. UK Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 38. UK Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 39. UK Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 40. Italy Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 41. Italy Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 42. Italy Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 43. Spain Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 44. Spain Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 45. Spain Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 46. Rest of Europe Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 47. Rest of Europe Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 48. Rest of Europe Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 49. Asia-Pacific Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 50. Asia-Pacific Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 51. Asia-Pacific Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 52. Asia-Pacific Laser Bph Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 53. Japan Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 54. Japan Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 55. Japan Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 56. China Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 57. China Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 58. China Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 59. India Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 60. India Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 61. India Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 62. Australia Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 63. Australia Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 64. Australia Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 65. South Korea Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 66. South Korea Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 67. South Korea Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 68. Rest of Asia-Pacific Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 69. Rest of Asia-Pacific Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 70. Rest of Asia-Pacific Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 71. LAMEA Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 72. LAMEA Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 73. LAMEA Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 74. LAMEA Laser Bph Devices Market, by Country, 2021-2031 (Revenue, $Million)
Table 75. Brazil Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 76. Brazil Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 77. Brazil Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 78. Saudi Arabia Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 79. Saudi Arabia Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 80. Saudi Arabia Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 81. South Africa Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 82. South Africa Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 83. South Africa Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 84. Rest of LAMEA Laser Bph Devices Market, by Type, 2021-2031 (Revenue, $Million)
Table 85. Rest of LAMEA Laser Bph Devices Market, by Procedure, 2021-2031 (Revenue, $Million)
Table 86. Rest of LAMEA Laser Bph Devices Market, by End-user, 2021-2031 (Revenue, $Million)
Table 87. Boston Scientific Corporation: Key Executives
Table 88. Boston Scientific Corporation: Company Snapshot
Table 89. Boston Scientific Corporation: Product Segments
Table 90. Boston Scientific Corporation: Product Portfolio
Table 91. Boston Scientific Corporation: Key Stratergies
Table 92. Coloplast: Key Executives
Table 93. Coloplast: Company Snapshot
Table 94. Coloplast: Product Segments
Table 95. Coloplast: Product Portfolio
Table 96. Biolitec Ag: Key Executives
Table 97. Biolitec Ag: Company Snapshot
Table 98. Biolitec Ag: Product Segments
Table 99. Biolitec Ag: Product Portfolio
Table 100. Richard Wolf Gmbh: Key Executives
Table 101. Richard Wolf Gmbh: Company Snapshot
Table 102. Richard Wolf Gmbh: Product Segments
Table 103. Richard Wolf Gmbh: Product Portfolio
Table 104. Agiliti Health, Inc.: Key Executives
Table 105. Agiliti Health, Inc.: Company Snapshot
Table 106. Agiliti Health, Inc.: Product Segments
Table 107. Agiliti Health, Inc.: Product Portfolio
Table 108. Healthtronics, Inc.: Key Executives
Table 109. Healthtronics, Inc.: Company Snapshot
Table 110. Healthtronics, Inc.: Product Segments
Table 111. Healthtronics, Inc.: Product Portfolio
Table 112. Endo Pharmaceuticals Inc.: Key Executives
Table 113. Endo Pharmaceuticals Inc.: Company Snapshot
Table 114. Endo Pharmaceuticals Inc.: Product Segments
Table 115. Endo Pharmaceuticals Inc.: Product Portfolio
Table 116. Omniguide: Key Executives
Table 117. Omniguide: Company Snapshot
Table 118. Omniguide: Product Segments
Table 119. Omniguide: Product Portfolio
Table 120. Metrum Cryoflex: Key Executives
Table 121. Metrum Cryoflex: Company Snapshot
Table 122. Metrum Cryoflex: Product Segments
Table 123. Metrum Cryoflex: Product Portfolio
Table 124. Teleflex Incorporated: Key Executives
Table 125. Teleflex Incorporated: Company Snapshot
Table 126. Teleflex Incorporated: Product Segments
Table 127. Teleflex Incorporated: Product Portfolio
Table 128. Teleflex Incorporated: Key Stratergies
List of Figures
Figure 01. Laser Bph Devices Market, 2021-2031
Figure 02. Segmentation of Laser Bph Devices Market, 2021-2031
Figure 03. Top Investment Pockets in Laser Bph Devices Market (2022-2031)
Figure 04. High Bargaining Power of Suppliers
Figure 05. Moderate Bargaining Power of Buyers
Figure 06. High Threat of Substitutes
Figure 07. High Threat of New Entrants
Figure 08. High Intensity of Rivalry
Figure 09. Drivers, Restraints and Opportunities: Globallaser Bph Devices Market
Figure 10. Laser Bph Devices Market, by Type, 2021 (%)
Figure 11. Comparative Share Analysis of Laser Bph Devices Market for Holmium Laser, by Country 2021-2031 (%)
Figure 12. Comparative Share Analysis of Laser Bph Devices Market for Thulium Laser, by Country 2021-2031 (%)
Figure 13. Comparative Share Analysis of Laser Bph Devices Market for Green Light Laser, by Country 2021-2031 (%)
Figure 14. Comparative Share Analysis of Laser Bph Devices Market for Others, by Country 2021-2031 (%)
Figure 15. Laser Bph Devices Market, by Procedure, 2021 (%)
Figure 16. Comparative Share Analysis of Laser Bph Devices Market for Photoselective Vaporisation of the Prostate, by Country 2021-2031 (%)
Figure 17. Comparative Share Analysis of Laser Bph Devices Market for Holmium Laser Ablation of the Prostate, by Country 2021-2031 (%)
Figure 18. Laser Bph Devices Market, by End-user, 2021 (%)
Figure 19. Comparative Share Analysis of Laser Bph Devices Market for Hospitals, by Country 2021-2031 (%)
Figure 20. Comparative Share Analysis of Laser Bph Devices Market for Clinics, by Country 2021-2031 (%)
Figure 21. Comparative Share Analysis of Laser Bph Devices Market for Others, by Country 2021-2031 (%)
Figure 22. Laser Bph Devices Market by Region, 2021
Figure 23. U.S. Laser Bph Devices Market, 2021-2031 ($Million)
Figure 24. Canada Laser Bph Devices Market, 2021-2031 ($Million)
Figure 25. Mexico Laser Bph Devices Market, 2021-2031 ($Million)
Figure 26. Germany Laser Bph Devices Market, 2021-2031 ($Million)
Figure 27. France Laser Bph Devices Market, 2021-2031 ($Million)
Figure 28. UK Laser Bph Devices Market, 2021-2031 ($Million)
Figure 29. Italy Laser Bph Devices Market, 2021-2031 ($Million)
Figure 30. Spain Laser Bph Devices Market, 2021-2031 ($Million)
Figure 31. Rest of Europe Laser Bph Devices Market, 2021-2031 ($Million)
Figure 32. Japan Laser Bph Devices Market, 2021-2031 ($Million)
Figure 33. China Laser Bph Devices Market, 2021-2031 ($Million)
Figure 34. India Laser Bph Devices Market, 2021-2031 ($Million)
Figure 35. Australia Laser Bph Devices Market, 2021-2031 ($Million)
Figure 36. South Korea Laser Bph Devices Market, 2021-2031 ($Million)
Figure 37. Rest of Asia-Pacific Laser Bph Devices Market, 2021-2031 ($Million)
Figure 38. Brazil Laser Bph Devices Market, 2021-2031 ($Million)
Figure 39. Saudi Arabia Laser Bph Devices Market, 2021-2031 ($Million)
Figure 40. South Africa Laser Bph Devices Market, 2021-2031 ($Million)
Figure 41. Rest of LAMEA Laser Bph Devices Market, 2021-2031 ($Million)
Figure 42. Top Winning Strategies, by Year
Figure 43. Top Winning Strategies, by Development
Figure 44. Top Winning Strategies, by Company
Figure 45. Product Mapping of Top 10 Players
Figure 46. Competitive Dashboard
Figure 47. Competitive Heatmap: Laser Bph Devices Market
Figure 48. Top Player Positioning, 2021
Figure 49. Boston Scientific Corporation: Net Sales, 2019-2021 ($Million)
Figure 50. Boston Scientific Corporation: Revenue Share by Segment, 2021 (%)
Figure 51. Boston Scientific Corporation: Revenue Share by Region, 2021 (%)
Figure 52. Coloplast: Net Revenue, 2019-2021 ($Million)
Figure 53. Coloplast: Net Revenue, 2019-2021 ($Million)
Figure 54. Coloplast: Revenue Share by Segment, 2021 (%)
Figure 55. Coloplast: Revenue Share by Region, 2021 (%)
Figure 56. Agiliti Health, Inc.: Net Revenue, 2019-2021 ($Million)
Figure 57. Endo Pharmaceuticals Inc.: Net Revenue, 2019-2021 ($Million)
Figure 58. Endo Pharmaceuticals Inc.: Revenue Share by Segment, 2021 (%)
Figure 59. Teleflex Incorporated: Net Revenue, 2019-2021 ($Million)
Figure 60. Teleflex Incorporated: Revenue Share by Segment, 2021 (%)
Figure 61. Teleflex Incorporated: Revenue Share by Region, 2021 (%)
Executive Summary
According to the report titled, “Laser BPH Devices Market," The laser BPH devices market was valued at $460.25 million in 2021, and is estimated to reach $765.4 million by 2031, growing at a CAGR of 5.2% from 2022 to 2031. Benign prostatic hyperplasia (BPH) is a condition that occurs when the prostate gland enlarges, potentially slowing or blocking the urine stream. Laser BPH devices such as holmium laser, thulium laser, green light laser, and others are used to treat benign prostatic hyperplasia. Others include diode laser, ND: YAG laser, KTP/Nd: YAG laser There are two types of procedures such as photoselective vaporization of the Prostate (PVP) and holmium laser ablation of the prostate (HoLAP) are used to treat benign prostatic hyperplasia. The end users of laser BPH devices are hospitals, clinics, and others. Others include ambulatory surgical centers.Key factors driving the growth of the Laser BPH devices market include increase in the prevalence of benign prostate hyperplasia, Rise in the number of geriatric populations, rise in the prevalence of obesity and increase in the prevalence of diabetes. Increase in the prevalence of diabetes can leads to rise in risk of benign prostatic hyperplasia (BPH). Diabetes is reported to be associated with greater BPH symptom severity. Men with non-insulin-dependent diabetes had the highest median annual prostate growth rate compared with those who had other metabolic disease. Systemic inflammation and oxidative stress caused by diabetes can cause prostatic hyperplasia. diabetes may reduce maximum flow rate of urine in BPH patients. The decrease in maximum flow rate of urine indicates that the contractile function of bladder detrusor is weakened, or the bladder neck and urethral outlet are narrow or obstructed. Alternatively, diabetes-related insulin resistance/hyperinsulinemia/hyperglycemia-induced obesity may cause hormonal changes. Hyperinsulinemia is associated with lower levels of sex hormone-binding globulin, increasing the amount of sex hormone entering prostatic cells thereby influencing growth of prostate and can raise the risk of BPH. Thus, increase in prevalence of diabetes cause rise in incidence of BPH which causes increase in demand for laser BPH devices. Therefore, this factor is anticipated to drive the growth of market. For instance, according to International Diabetes Federation, in 2021, it was reported that, 537 million adults (20-79 years) are living with diabetes (1 in 10) worldwide. This number is predicted to rise to 643 million by 2030 and 783 million by 2045. As per the same source, it was reported that, over 3 in 4 adults with diabetes live in low- and middle-income countries.
The market also offers growth opportunities to the key players in the market. For instance, rise in the number of populations suffering from benign prostate hyperplasia is anticipated to drive the growth of market. For instance, according to The Lancet Article, in 2019, it was reported that, about 9,48,000 population in France and 13,80,000 population in Germany is suffering from benign prostate hyperplasia.
The laser BPH devices market is segmented based on type, procedure, end user and region. Based on type the market is segmented into holmium laser, thulium laser, green light laser, and others. On the basis of procedure, the market is segmented into photo selective vaporization of the Prostate (PVP) and holmium laser ablation of the prostate (HoLAP). On the basis of end user, the market is segmented into hospitals, clinics, and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and rest of Europe), Asia-Pacific (China, India, Japan, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
The key players profiled in the study include Boston Scientific, Agiliti Health, Inc., Asclepion Laser Technologies GmbH, Biolitec AG., Coloplast, Endo Pharmaceuticals Inc., HealthTronics, Inc., Lumenis, Metrum Cryoflex, OmniGuide and Richard Wolf GmbH. The players in the market have been actively engaged in the adoption various strategies such as acquisition, product launch and expansion to remain competitive and gain advantage over the competitors in the market. For instance, in September 2021, Boston Scientific Corporation announced the acquisition of the global surgical business of Lumenis Ltd. The acquisition of Lumenis Ltd. will help to strengthen the product portfolio of laser systems.
Key Market Insights
- By type, the holmium laser segment was the highest revenue contributor to the market and is estimated to reach $317.4 million by 2031, with a CAGR of 5.3%. However, the green light laser segment is estimated to be the fastest-growing segment with a CAGR of 5.8% during the forecast period.
- By procedure, the holmium laser ablation of the prostate (Ho
- LAP) segment dominated the global market. However, the holmium laser ablation of the prostate (Ho
- LAP) segment is expected to be the fastest-growing segment with a CAGR of 5.2% during the forecast period.
- Based on end user, the hospitals segment was the highest revenue contributor to the market with a CAGR of 5.4% during the forecast period.
- Based on region, North America garnered the largest revenue share in 2021, whereas Asia-Pacific is anticipated to grow at the highest CAGR of 6.3% during the forecast period
Companies Mentioned
- Boston Scientific Corporation
- OmniGuide
- Metrum Cryoflex
- Richard Wolf GmbH
- Coloplast
- Biolitec AG
- Agiliti Health, Inc.
- HealthTronics, Inc.
- Endo Pharmaceuticals Inc.
- Teleflex Incorporated
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 239 |
| Published | December 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 460.3 million |
| Forecasted Market Value ( USD | $ 765.4 million |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
